IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 193 filers reported holding IMMUNOGEN INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,000 | -15.9% | 126 | 0.0% | 0.00% | – |
| Q2 2023 | $2,378 | +391.3% | 126 | 0.0% | 0.00% | – |
| Q1 2023 | $484 | -22.6% | 126 | 0.0% | 0.00% | – |
| Q4 2022 | $625 | -37.5% | 126 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 126 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 126 | -53.0% | 0.00% | – |
| Q1 2022 | $1,000 | -99.4% | 268 | -98.8% | 0.00% | -100.0% |
| Q4 2021 | $169,000 | +31.0% | 22,768 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $129,000 | -14.0% | 22,768 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $150,000 | -18.5% | 22,768 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $184,000 | +12.9% | 22,768 | -9.9% | 0.00% | 0.0% |
| Q4 2020 | $163,000 | +16200.0% | 25,268 | +9088.4% | 0.00% | – |
| Q1 2020 | $1,000 | – | 275 | +105.2% | 0.00% | – |
| Q2 2019 | $0 | – | 134 | +36.7% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 98 | -30.5% | 0.00% | – |
| Q3 2018 | $1,000 | – | 141 | +540.9% | 0.00% | – |
| Q1 2014 | $0 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |